Go Pro

Equus Total Return (EQS) Financials

Equus Total Return logo
$1.13 -0.05 (-4.04%)
As of 07/20/2026 01:30 PM Eastern
Annual Income Statements for Equus Total Return

Annual Income Statements for Equus Total Return

This table shows Equus Total Return's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-12 2.59 -1.13 13 -19 -14
Consolidated Net Income / (Loss)
-12 2.59 -1.13 13 -19 -14
Net Income / (Loss) Continuing Operations
-12 2.59 -1.13 13 -19 -14
Total Pre-Tax Income
-12 2.63 -1.13 13 -19 -14
Total Revenue
-2.27 6.08 2.50 17 -14 -14
Net Interest Income / (Expense)
-1.56 5.65 2.50 17 -15 -15
Total Interest Income
0.29 0.00 0.00 17 -15 -15
Investment Securities Interest Income
-1.53 5.65 2.50 17 -15 -15
Total Interest Expense
0.03 0.00 0.00 0.00 0.00 0.00
Total Non-Interest Income
-0.71 0.43 0.00 0.23 1.25 1.37
Net Realized & Unrealized Capital Gains on Investments
- - - 0.23 1.25 1.37
Total Non-Interest Expense
10 3.45 3.63 4.28 4.59 5.51
Salaries and Employee Benefits
3.16 1.63 1.56 1.94 1.76 2.15
Other Operating Expenses
6.86 1.82 2.06 2.35 2.83 3.37
Nonoperating Income / (Expense), net
- - - 0.00 0.00 5.36
Basic Earnings per Share
- - - $0.96 ($1.38) ($1.03)
Weighted Average Basic Shares Outstanding
- - 13.52M 13.53M 13.59M 13.71M
Diluted Earnings per Share
($0.91) $0.19 ($0.08) $0.96 ($1.38) ($1.03)
Weighted Average Diluted Shares Outstanding
13.52M 13.52M 13.52M 13.53M 13.59M 13.71M

Quarterly Income Statements for Equus Total Return

This table shows Equus Total Return's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
7.08 1.06 -2.40 3.90 -9.63 -11 3.94 -0.09 -8.10 -9.92
Consolidated Net Income / (Loss)
7.08 0.26 -2.09 3.87 -9.68 -11 3.94 -0.09 -8.10 -9.92
Net Income / (Loss) Continuing Operations
7.08 0.26 -2.09 3.87 -9.68 -11 3.94 -0.09 -8.10 -9.92
Total Pre-Tax Income
7.08 0.26 -1.00 3.87 -9.68 -12 3.94 -0.09 -8.10 -9.92
Total Revenue
8.24 2.18 0.33 5.08 -8.67 -11 5.36 0.83 -5.19 -15
Net Interest Income / (Expense)
8.23 1.98 0.04 5.08 -8.67 -12 5.20 0.83 -5.55 -16
Total Interest Income
8.24 1.97 0.04 5.08 -8.67 -12 5.23 0.88 -5.55 -16
Investment Securities Interest Income
8.24 1.97 0.04 5.08 -8.67 -12 5.23 0.88 -5.55 -16
Total Interest Expense
0.01 -0.01 0.00 0.00 0.00 - 0.03 0.05 0.00 -0.08
Total Non-Interest Income
0.01 0.20 0.28 0.00 0.00 0.96 0.16 0.00 0.36 0.86
Net Realized & Unrealized Capital Gains on Investments
0.01 0.20 0.28 - - - 0.32 0.00 0.36 0.70
Total Non-Interest Expense
1.16 1.92 1.37 1.21 1.02 0.99 1.42 0.92 2.91 0.27
Salaries and Employee Benefits
0.69 - 0.43 0.48 0.43 0.43 0.57 0.43 0.92 0.23
Other Operating Expenses
0.47 0.67 0.95 0.73 0.59 0.56 0.85 0.48 1.99 0.04
Basic Earnings per Share
- - - $0.29 - - $0.30 ($0.01) ($0.59) ($0.73)
Weighted Average Basic Shares Outstanding
13.52M 13.53M 13.59M 13.59M 13.59M 13.59M 13.59M 13.59M 13.68M 13.71M
Diluted Earnings per Share
$0.52 $0.08 ($0.17) - ($0.70) - $0.25 ($0.01) ($0.59) ($0.68)
Weighted Average Diluted Shares Outstanding
13.52M 13.53M 13.59M 13.59M 13.59M 13.59M 15.55M 13.59M 13.68M 13.71M
Weighted Average Basic & Diluted Shares Outstanding
13.52M 13.59M 13.59M 13.59M 13.59M 13.59M 13.59M 13.59M 13.97M 0.00

Annual Cash Flow Statements for Equus Total Return

This table details how cash moves in and out of Equus Total Return's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
20 -0.39 -4.21 -12 -6.72 -0.13
Net Cash From Operating Activities
25 21 -7.70 -51 38 -2.13
Net Cash From Continuing Operating Activities
25 21 -7.70 -51 38 -2.13
Net Income / (Loss) Continuing Operations
-12 2.59 -1.13 13 -19 -14
Consolidated Net Income / (Loss)
-12 2.59 -1.13 13 -19 -14
Amortization Expense
- - - 0.00 0.00 0.50
Non-Cash Adjustments to Reconcile Net Income
39 16 -6.15 -64 58 11
Changes in Operating Assets and Liabilities, net
-1.67 2.59 -0.43 -0.15 -1.30 0.10
Net Cash From Investing Activities
0.00 0.00 0.00 0.00 0.00 0.00
Net Cash From Continuing Investing Activities
0.00 0.00 0.00 0.00 0.00 0.00
Net Cash From Financing Activities
-4.99 -22 3.50 39 -45 2.00
Net Cash From Continuing Financing Activities
-4.99 -22 3.50 39 -45 2.00
Issuance of Common Equity
- - - 0.10 0.00 2.00
Repayment of Debt
-109 -24 -13 -47 -207 0.00
Other Financing Activities, Net
104 - - 86 162 0.00
Cash Interest Paid
0.01 0.00 0.00 0.03 0.14 0.18

Quarterly Cash Flow Statements for Equus Total Return

This table details how cash moves in and out of Equus Total Return's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q3 2025 Q4 2025
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 9/30/2025 12/31/2025
Net Change in Cash & Equivalents
-2.69 -6.87 -3.40 -1.16 -0.72 -1.44 0.41 0.26 -0.20
Net Cash From Operating Activities
-7.68 -34 -11 -2.14 -1.77 54 -1.60 0.26 -0.20
Net Cash From Continuing Operating Activities
-7.68 -34 -13 -0.79 -1.77 54 -1.60 0.26 -0.20
Net Income / (Loss) Continuing Operations
12 1.06 -2.40 2.40 -8.12 -11 3.94 - -14
Amortization Expense
- - - - - - - - 0.14
Non-Cash Adjustments to Reconcile Net Income
-20 -35 -10 -2.87 6.45 65 -4.97 -2.11 15
Changes in Operating Assets and Liabilities, net
0.09 -0.23 -0.11 -0.31 -0.09 -0.78 -0.57 0.85 -0.14
Cash Interest Paid
0.01 0.01 0.00 0.07 0.06 0.01 0.03 0.05 0.05

Annual Balance Sheets for Equus Total Return

This table presents Equus Total Return's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024 2025
Period end date 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
40 42 94 30 21
Cash and Due from Banks
23 19 6.53 0.26 0.13
Trading Account Securities
13 16 41 28 11
Loans and Leases, Net of Allowance
0.00 0.00 0.00 0.00 0.00
Other Assets
3.23 6.73 0.53 2.17 11
Total Liabilities & Shareholders' Equity
40 42 62 134 154
Total Liabilities
3.35 6.43 45 0.43 4.77
Long-Term Debt
2.50 6.00 45 0.00 2.12
Other Long-Term Liabilities
0.85 0.43 0.31 0.43 2.65
Total Equity & Noncontrolling Interests
36 35 17 134 149
Total Preferred & Common Equity
36 35 48 30 17
Total Common Equity
36 35 17 134 149
Common Stock
75 75 88 88 90
Retained Earnings
-38 -39 -27 45 59

Quarterly Balance Sheets for Equus Total Return

This table presents Equus Total Return's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025
Period end date 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025
Total Assets
66 99 104 96 36 37 31
Cash and Due from Banks
14 3.05 1.88 1.15 0.67 0.07 0.33
Trading Account Securities
33 95 47 38 25 23 23
Loans and Leases, Net of Allowance
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Assets
19 0.84 0.98 1.31 11 14 8.22
Total Liabilities & Shareholders' Equity
66 99 63 54 50 51 45
Total Liabilities
18 53 54 55 2.29 2.96 4.90
Long-Term Debt
18 53 54 55 1.59 - 1.93
Other Long-Term Liabilities
0.42 0.28 0.11 0.35 0.70 1.31 2.97
Total Equity & Noncontrolling Interests
47 46 9.43 -1.24 48 48 40
Total Preferred & Common Equity
47 46 50 40 34 34 27
Total Common Equity
47 46 9.42 -1.24 48 48 40
Common Stock
75 75 88 88 89 89 90
Retained Earnings
-28 -29 -25 -35 -41 -41 -50
Other Equity Adjustments
- - - - - - 0.01

Annual Metrics And Ratios for Equus Total Return

This table displays calculated financial ratios and metrics derived from Equus Total Return's official financial filings.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
0.00 0.00 13,518,146.00 13,518,146.00 13,586,173.00 13,966,696.00
DEI Adjusted Shares Outstanding
0.00 0.00 13,518,146.00 13,518,146.00 13,586,173.00 13,966,696.00
DEI Earnings Per Adjusted Shares Outstanding
0.00 0.00 -0.08 0.96 -1.38 -1.01
Growth Metrics
- - - - - -
Revenue Growth
0.00% 367.31% -58.90% 590.15% -182.33% 1.27%
EBITDA Growth
0.00% 121.36% -142.96% 1,247.96% -245.01% -1.29%
EBIT Growth
0.00% 121.36% -142.96% 1,247.96% -245.01% -3.96%
NOPAT Growth
0.00% 130.08% -130.51% 1,739.94% -201.51% -3.96%
Net Income Growth
0.00% 121.05% -143.59% 1,247.96% -245.01% 24.57%
EPS Growth
0.00% 120.88% -142.11% 1,300.00% -243.75% 25.36%
Operating Cash Flow Growth
0.00% -14.23% -136.49% -566.65% 174.44% -105.57%
Free Cash Flow Firm Growth
0.00% 0.00% 91.29% -1,136.17% 229.52% -105.63%
Invested Capital Growth
0.00% 0.00% 6.10% 126.12% -68.35% -36.66%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 0.00% -153.37% 177.62% 0.00%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics
- - - - - -
EBITDA Margin
0.00% 43.22% -45.17% 75.14% 0.00% 0.00%
EBIT Margin
0.00% 43.22% -45.17% 75.14% 0.00% 0.00%
Profit (Net Income) Margin
0.00% 42.59% -45.17% 75.14% 0.00% 0.00%
Tax Burden Percent
100.00% 98.55% 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 72.56%
Effective Tax Rate
0.00% 1.45% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 13.32% -1.97% 19.26% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 13.32% -9.94% 19.26% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.92% -1.18% 30.40% 0.00% 0.00%
Return on Equity (ROE)
0.00% 14.23% -3.15% 49.66% -24.94% -10.01%
Cash Return on Invested Capital (CROIC)
0.00% -186.68% -7.89% -58.09% 82.42% -11.82%
Operating Return on Assets (OROA)
0.00% 6.61% -2.77% 19.15% 0.00% 0.00%
Return on Assets (ROA)
0.00% 6.52% -2.77% 19.15% 0.00% 0.00%
Return on Common Equity (ROCE)
0.00% 14.23% -3.15% 49.66% -24.94% -10.01%
Return on Equity Simple (ROE_SIMPLE)
0.00% 7.12% -3.20% 26.82% -63.63% -85.48%
Net Operating Profit after Tax (NOPAT)
-8.60 2.59 -0.79 13 -13 -14
NOPAT Margin
0.00% 42.59% -31.62% 75.14% 0.00% 0.00%
Net Nonoperating Expense Percent (NNEP)
0.00% 0.00% 7.96% 0.00% -40.47% -0.43%
SG&A Expenses to Revenue
0.00% 26.86% 62.64% 11.24% 0.00% 0.00%
Operating Expenses to Revenue
0.00% 56.78% 145.17% 24.86% 0.00% 0.00%
Earnings before Interest and Taxes (EBIT)
-12 2.63 -1.13 13 -19 -20
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-12 2.63 -1.13 13 -19 -19
Valuation Ratios
- - - - - -
Price to Book Value (P/BV)
0.00 0.88 0.55 1.16 0.11 0.13
Price to Tangible Book Value (P/TBV)
0.00 0.88 0.55 1.16 0.11 0.13
Price to Revenue (P/Rev)
0.00 5.29 7.74 1.14 0.00 0.00
Price to Earnings (P/E)
0.00 12.43 0.00 1.51 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 8.05% 0.00% 66.02% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.29 0.15 0.62 0.50 1.14
Enterprise Value to Revenue (EV/Rev)
0.00 1.84 2.42 3.34 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)
0.00 4.26 0.00 4.45 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 4.26 0.00 4.45 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 4.32 0.00 4.45 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.53 0.00 0.00 0.38 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.29 0.00
Leverage & Solvency
- - - - - -
Debt to Equity
0.00 0.07 0.17 2.66 0.00 0.01
Long-Term Debt to Equity
0.00 0.07 0.17 2.66 0.00 0.01
Financial Leverage
0.00 0.07 0.12 1.58 -0.18 -0.83
Leverage Ratio
0.00 1.09 1.14 2.59 0.82 0.18
Compound Leverage Factor
0.00 1.09 1.14 2.59 0.82 0.13
Debt to Total Capital
0.00% 6.43% 14.55% 72.66% 0.00% 1.40%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 6.43% 14.55% 72.66% 0.00% 1.40%
Preferred Equity to Total Capital
0.00% 0.03% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
0.00% 93.53% 85.45% 27.34% 100.00% 98.60%
Debt to EBITDA
0.00 0.95 -5.32 3.47 0.00 -0.11
Net Debt to EBITDA
0.00 -7.99 11.78 2.93 0.00 -0.10
Long-Term Debt to EBITDA
0.00 0.95 -5.32 3.47 0.00 -0.11
Debt to NOPAT
0.00 0.97 -7.60 3.47 0.00 -0.16
Net Debt to NOPAT
0.00 -8.11 16.83 2.93 0.00 -0.15
Long-Term Debt to NOPAT
0.00 0.97 -7.60 3.47 0.00 -0.16
Noncontrolling Interest Sharing Ratio
0.00% 0.04% 0.02% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - -
Cash Flow Metrics
- - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -36 -3.16 -39 51 -2.85
Operating Cash Flow to CapEx
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense
0.00 -12,092.33 -789.90 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
911.63 7,037.00 -1,926.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
911.63 7,037.00 -1,926.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - -
Asset Turnover
0.00 0.15 0.06 0.25 0.00 0.00
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics
- - - - - -
Invested Capital
0.00 39 41 93 30 19
Invested Capital Turnover
0.00 0.31 0.06 0.26 0.00 0.00
Increase / (Decrease) in Invested Capital
0.00 39 2.37 52 -64 -11
Enterprise Value (EV)
0.00 11 6.04 58 15 21
Market Capitalization
29 32 19 20 15 19
Book Value per Share
$0.00 $2.69 $2.61 $1.25 $9.84 $11.05
Tangible Book Value per Share
$0.00 $2.69 $2.61 $1.25 $9.84 $11.05
Total Capital
0.00 39 41 62 134 152
Total Debt
0.00 2.50 6.00 45 0.00 2.12
Total Long-Term Debt
0.00 2.50 6.00 45 0.00 2.12
Net Debt
0.00 -21 -13 38 -0.26 1.99
Capital Expenditures (CapEx)
0.00 0.00 0.00 0.00 0.00 0.00
Net Nonoperating Expense (NNE)
3.69 0.00 0.34 0.00 5.63 0.50
Net Nonoperating Obligations (NNO)
0.00 2.50 6.00 76 -104 -131
Total Depreciation and Amortization (D&A)
0.00 0.00 0.00 0.00 0.00 0.50
Earnings Adjustments
- - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $0.00 $0.00 ($1.38) ($1.03)
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 13.52M 13.59M 13.59M 13.71M
Adjusted Diluted Earnings per Share
$0.00 $0.00 ($0.08) $0.96 $0.00 ($1.03)
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 13.52M 13.53M 13.59M 13.71M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 13.52M 13.59M 13.59M 0.00
Normalized Net Operating Profit after Tax (NOPAT)
-8.60 2.59 -0.79 9.06 -13 -14
Normalized NOPAT Margin
0.00% 42.59% -31.62% 52.60% 0.00% 0.00%
Pre Tax Income Margin
0.00% 43.22% -45.17% 75.14% 0.00% 0.00%
Debt Service Ratios
- - - - - -
EBIT to Interest Expense
-455.26 875.33 -282.00 0.00 0.00 0.00
NOPAT to Interest Expense
-318.68 862.67 -197.40 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
-455.26 875.33 -282.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
-318.68 862.67 -197.40 0.00 0.00 0.00
Payout Ratios
- - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Equus Total Return

This table displays calculated financial ratios and metrics derived from Equus Total Return's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025
DEI Shares Outstanding
13,518,146.00 13,518,146.00 13,586,173.00 13,586,173.00 13,586,173.00 13,586,173.00 13,586,173.00 13,586,173.00 13,966,696.00 13,966,696.00
DEI Adjusted Shares Outstanding
13,518,146.00 13,518,146.00 13,586,173.00 13,586,173.00 13,586,173.00 13,586,173.00 13,586,173.00 13,586,173.00 13,966,696.00 13,966,696.00
DEI Earnings Per Adjusted Shares Outstanding
0.52 0.02 -0.15 0.28 -0.71 -0.80 0.29 -0.01 -0.58 -0.71
Growth Metrics
- - - - - - - - - -
Revenue Growth
412,150.00% 217,400.00% 4,547.14% -25.41% -205.14% -602.45% 608.73% -83.65% 39.71% -37.34%
EBITDA Growth
865.08% 119.30% 7.37% -34.80% -237.04% -4,718.72% 264.63% -102.21% 15.85% -27.03%
EBIT Growth
865.08% 119.30% 7.37% -34.80% -237.04% -4,718.72% 264.63% -102.21% 15.85% -28.20%
NOPAT Growth
1,192.97% 127.57% 7.37% -34.80% -195.93% -3,345.31% 335.19% -101.54% 15.85% 17.07%
Net Income Growth
865.08% 119.30% -85.03% -34.80% -237.04% -4,313.68% 264.63% -102.21% 15.85% 8.75%
EPS Growth
842.86% 214.29% -112.50% 0.00% -234.62% 0.00% 247.06% -103.45% -184.29% 0.00%
Operating Cash Flow Growth
0.00% -1,091.23% -108.36% 49.81% 0.00% 257.81% 86.03% 0.00% 114.71% -100.37%
Free Cash Flow Firm Growth
0.00% 0.00% 0.00% 0.00% 0.00% 206.98% 0.00% 0.00% 0.00% -93.00%
Invested Capital Growth
0.00% 126.12% 0.00% 0.00% 0.00% -68.35% 0.00% 0.00% 0.00% -36.66%
Revenue Q/Q Growth
20.98% -73.61% 0.00% 1,461.94% -270.69% -26.11% 0.00% 0.00% -725.42% -189.14%
EBITDA Q/Q Growth
19.22% -96.35% 0.00% 469.38% -348.28% -23.06% 0.00% 0.00% -9,319.77% -86.85%
EBIT Q/Q Growth
19.22% -96.35% 0.00% 469.38% -348.28% -23.06% 0.00% 0.00% -9,319.77% -88.58%
NOPAT Q/Q Growth
19.22% -96.35% 0.00% 627.69% -273.80% -23.53% 0.00% 0.00% -9,319.77% -22.45%
Net Income Q/Q Growth
19.22% -96.35% 0.00% 284.93% -348.28% -12.27% 0.00% 0.00% -9,319.77% -22.45%
EPS Q/Q Growth
0.00% -84.62% 0.00% 0.00% -341.38% 0.00% 0.00% 0.00% -5,800.00% -15.25%
Operating Cash Flow Q/Q Growth
-80.44% -341.73% 0.00% 81.28% 0.00% 3,130.90% 0.00% 0.00% 0.00% -175.38%
Free Cash Flow Firm Q/Q Growth
0.00% 10.84% 0.00% -0.27% 0.00% 154.31% 0.00% 0.00% 4.77% 111.36%
Invested Capital Q/Q Growth
0.00% 43.20% 0.00% 4.93% 0.00% -68.99% 0.00% 0.00% -20.47% -34.26%
Profitability Metrics
- - - - - - - - - -
EBITDA Margin
85.88% 11.86% -322.07% 76.17% 0.00% 0.00% 73.54% -10.36% 0.00% 0.00%
EBIT Margin
85.88% 11.86% -322.07% 76.17% 0.00% 0.00% 73.54% -10.36% 0.00% 0.00%
Profit (Net Income) Margin
85.88% 11.86% -643.31% 76.17% 0.00% 0.00% 73.54% -10.36% 0.00% 0.00%
Tax Burden Percent
100.00% 100.00% 208.71% 100.00% 100.00% 90.89% 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent
100.00% 100.00% 95.70% 100.00% 100.00% 100.38% 100.00% 100.00% 100.00% 64.93%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 3.04% -79.94% 23.19% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 3.04% -85.07% 23.19% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
0.00% 4.80% -98.19% 231.85% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)
0.00% 7.84% -178.12% 255.05% 0.00% -24.94% 0.00% 0.00% 0.00% -10.01%
Cash Return on Invested Capital (CROIC)
0.00% -58.09% 0.00% 0.00% 0.00% 82.42% 0.00% 0.00% 0.00% -11.82%
Operating Return on Assets (OROA)
0.00% 3.02% -56.94% 11.59% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Assets (ROA)
0.00% 3.02% -113.73% 11.59% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Common Equity (ROCE)
0.00% 7.84% -178.07% 254.67% 0.00% -24.94% 0.00% 0.00% 0.00% -10.01%
Return on Equity Simple (ROE_SIMPLE)
0.00% 0.00% 26.12% 19.93% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
7.08 0.26 -0.73 3.87 -6.78 -8.37 3.94 -0.06 -5.67 -6.94
NOPAT Margin
85.88% 11.86% -225.45% 76.17% 0.00% 0.00% 73.54% -7.25% 0.00% 0.00%
Net Nonoperating Expense Percent (NNEP)
0.00% 0.00% 5.13% 0.00% 6.03% -17.95% 0.00% -0.43% -40.39% -2.53%
SG&A Expenses to Revenue
8.40% 0.00% 131.57% 9.39% 0.00% 0.00% 10.63% 52.17% 0.00% 0.00%
Operating Expenses to Revenue
14.12% 88.14% 422.07% 23.83% 0.00% 0.00% 26.46% 110.36% 0.00% 0.00%
Earnings before Interest and Taxes (EBIT)
7.08 0.26 -1.05 3.87 -9.68 -12 3.94 -0.09 -8.10 -15
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
7.08 0.26 -1.05 3.87 -9.68 -12 3.94 -0.09 -8.10 -15
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
0.42 1.16 0.43 1.90 0.00 0.11 0.33 0.39 0.76 0.13
Price to Tangible Book Value (P/TBV)
0.42 1.16 0.43 1.90 0.00 0.11 0.33 0.39 0.76 0.13
Price to Revenue (P/Rev)
0.00 1.14 1.13 1.14 0.00 0.00 0.00 0.00 0.00 0.00
Price to Earnings (P/E)
0.00 1.51 1.70 1.86 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 66.02% 58.91% 53.75% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.37 0.62 0.70 0.67 0.75 0.50 0.47 0.56 1.14 1.14
Enterprise Value to Revenue (EV/Rev)
0.00 3.34 3.95 4.40 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)
0.00 4.45 5.31 6.34 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 4.45 5.31 6.34 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 4.45 5.29 6.31 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.38 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.29 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
0.38 2.66 1.15 5.72 -44.28 0.00 0.03 0.03 0.05 0.01
Long-Term Debt to Equity
0.38 2.66 1.15 5.72 -44.28 0.00 0.03 0.00 0.05 0.01
Financial Leverage
0.38 1.58 1.15 10.00 -77.62 -0.18 -0.25 -0.25 -0.30 -0.83
Leverage Ratio
1.39 2.59 2.16 11.01 -76.90 0.82 0.76 0.78 0.78 0.18
Compound Leverage Factor
1.39 2.59 2.07 11.01 -76.90 0.82 0.76 0.78 0.78 0.12
Debt to Total Capital
27.62% 72.66% 53.58% 85.11% 102.31% 0.00% 3.22% 3.33% 4.56% 1.40%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 3.33% 0.00% 0.00%
Long-Term Debt to Total Capital
27.62% 72.66% 53.58% 85.11% 102.31% 0.00% 3.22% 0.00% 4.56% 1.40%
Preferred Equity to Total Capital
0.00% 0.00% 0.01% 0.02% 0.00% 0.00% 0.03% 0.03% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
72.38% 27.34% 46.41% 14.86% -2.31% 100.00% 96.75% 96.64% 95.44% 98.60%
Debt to EBITDA
0.00 3.47 4.06 4.92 0.00 0.00 0.00 0.00 0.00 -0.11
Net Debt to EBITDA
0.00 2.93 3.79 4.70 0.00 0.00 0.00 0.00 0.00 -0.10
Long-Term Debt to EBITDA
0.00 3.47 4.06 4.92 0.00 0.00 0.00 0.00 0.00 -0.11
Debt to NOPAT
0.00 3.47 4.05 4.90 0.00 0.00 0.00 0.00 0.00 -0.16
Net Debt to NOPAT
0.00 2.93 3.78 4.68 0.00 0.00 0.00 0.00 0.00 -0.15
Long-Term Debt to NOPAT
0.00 3.47 4.05 4.90 0.00 0.00 0.00 0.00 0.00 -0.16
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.03% 0.15% 0.00% 0.00% 0.03% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - -
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-58 -52 -100 -100 -102 55 -32 -36 -34 3.87
Operating Cash Flow to CapEx
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense
-4,836.50 0.00 0.00 0.00 0.00 0.00 -1,098.14 -702.22 0.00 0.00
Operating Cash Flow to Interest Expense
-640.25 0.00 0.00 0.00 0.00 0.00 -55.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
-640.25 0.00 0.00 0.00 0.00 0.00 -55.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.00 0.25 0.18 0.15 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
65 93 99 104 95 30 36 36 28 19
Invested Capital Turnover
0.00 0.26 0.35 0.30 0.00 0.00 0.00 0.00 0.00 0.00
Increase / (Decrease) in Invested Capital
65 52 99 104 95 -64 36 36 28 -11
Enterprise Value (EV)
24 58 69 69 72 15 17 20 32 21
Market Capitalization
20 20 20 18 18 15 16 18 31 19
Book Value per Share
$3.49 $1.25 $3.38 $0.69 ($0.09) $9.84 $3.52 $3.51 $2.96 $11.05
Tangible Book Value per Share
$3.49 $1.25 $3.38 $0.69 ($0.09) $9.84 $3.52 $3.51 $2.96 $11.05
Total Capital
65 62 99 63 54 134 49 49 42 152
Total Debt
18 45 53 54 55 0.00 1.59 1.64 1.93 2.12
Total Long-Term Debt
18 45 53 54 55 0.00 1.59 0.00 1.93 2.12
Net Debt
4.14 38 49 52 53 -0.26 0.93 1.57 1.60 1.99
Capital Expenditures (CapEx)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Nonoperating Expense (NNE)
0.00 0.00 1.36 0.00 2.90 2.50 0.00 0.03 2.43 2.98
Net Nonoperating Obligations (NNO)
18 76 53 94 96 -104 -12 -12 -12 -131
Total Depreciation and Amortization (D&A)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.14
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $0.00 $0.29 $0.00 $0.00 $0.30 ($0.01) ($0.59) ($0.73)
Adjusted Weighted Average Basic Shares Outstanding
13.52M 13.53M 13.59M 13.59M 13.59M 13.59M 13.59M 13.59M 13.68M 13.71M
Adjusted Diluted Earnings per Share
$0.52 $0.08 ($0.17) $0.00 ($0.70) $0.00 $0.25 ($0.01) ($0.59) ($0.68)
Adjusted Weighted Average Diluted Shares Outstanding
13.52M 13.53M 13.59M 13.59M 13.59M 13.59M 15.55M 13.59M 13.68M 13.71M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
13.52M 13.59M 13.59M 13.59M 13.59M 13.59M 13.59M 13.59M 13.97M 0.00
Normalized Net Operating Profit after Tax (NOPAT)
4.95 0.18 -0.73 2.71 -6.78 -8.37 2.76 -0.06 -5.67 -6.94
Normalized NOPAT Margin
60.11% 8.30% -225.45% 53.32% 0.00% 0.00% 51.48% -7.25% 0.00% 0.00%
Pre Tax Income Margin
85.88% 11.86% -308.24% 76.17% 0.00% 0.00% 73.54% -10.36% 0.00% 0.00%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
589.75 0.00 0.00 0.00 0.00 0.00 135.97 -1.69 0.00 0.00
NOPAT to Interest Expense
589.75 0.00 0.00 0.00 0.00 0.00 135.97 -1.18 0.00 0.00
EBIT Less CapEx to Interest Expense
589.75 0.00 0.00 0.00 0.00 0.00 135.97 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
589.75 0.00 0.00 0.00 0.00 0.00 135.97 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Equus Total Return (NYSE: EQS) showed a sharp deterioration in profitability and balance sheet strength in 2025, despite a strong start to the year and a still-liquid asset base.

Across the last four quarters, the company’s results have been highly volatile. EQS posted a profitable first quarter in 2025, but that was followed by steep losses in Q2, Q3, and Q4. The biggest weakness is clear in the income statement: investment income fell sharply from early 2025 levels, while expenses stayed elevated relative to revenue. By Q4 2025, the company reported a net loss of $9.9 million and diluted EPS of $(0.68).

On the cash flow side, operating performance also weakened. EQS generated positive operating cash flow in Q3 2025, but turned negative in Q4 2025 with $(196,000) from operating activities. That said, the company still appears to have some flexibility thanks to its cash position and portfolio of trading securities.

The balance sheet tells a more mixed story. EQS ended Q3 2025 with $31.4 million in assets and $40.5 million in common equity, but this compares with much larger asset levels earlier in 2024. Total assets declined materially from $103.8 million in Q2 2024 and $95.5 million in Q3 2024, reflecting a much smaller overall asset base today. Debt has also come down significantly from last year, which helps reduce financial risk.

  • Debt declined sharply from $54.0 million in Q2 2024 and $55.0 million in Q3 2024 to just $1.9 million in Q3 2025, which materially lowers leverage risk.
  • Common equity remained positive at $40.5 million in Q3 2025, giving the company a cushion despite recent losses.
  • Q1 2025 was profitable, with net income of $3.9 million and EPS of $0.30, showing the business can still produce earnings in favorable periods.
  • Q3 2025 operating cash flow was positive at $260,000, indicating the company can still generate cash in some quarters.
  • Trading securities remain the core asset, at $22.9 million in both Q2 and Q3 2025, so results are still heavily tied to investment performance.
  • Share count stayed relatively stable in 2025, with weighted average basic shares around 13.7 million, so losses were driven more by performance than dilution.
  • Cash improved modestly from $69,000 in Q2 2025 to $329,000 in Q3 2025, but remains limited.
  • Q4 2025 revenue was deeply negative at $(15.0 million), driven by a large negative swing in investment income.
  • Net loss widened materially in Q4 2025 to $(9.9 million) versus a loss of $(8.1 million) in Q3 2025.
  • Operating cash flow turned negative again in Q4 2025, suggesting the business is still struggling to convert earnings into cash consistently.

Bottom line: EQS has strengthened its leverage profile, but the operating trend is weak. The company’s income stream has become much more unstable, and the sharp drop in revenue and earnings in late 2025 is the main concern for investors. For retail investors, this looks like a balance sheet that is less risky than it was a year ago, but a business that is still highly exposed to swings in investment performance.

07/21/26 04:52 AM ETAI Generated. May Contain Errors.

Equus Total Return Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Equus Total Return's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Equus Total Return's net income appears to be on an upward trend, with a most recent value of -$14.16 million in 2025, rising from -$12.29 million in 2020. The previous period was -$18.78 million in 2024. Check out Equus Total Return's forecast to explore projected trends and price targets.

Over the last 5 years, Equus Total Return's total revenue changed from -$2.27 million in 2020 to -$14.01 million in 2025, a change of 516.3%.

Equus Total Return's total liabilities were at $4.77 million at the end of 2025, a 1,019.2% increase from 2024, and a 42.3% increase since 2021.

In the past 4 years, Equus Total Return's cash and equivalents has ranged from $133 thousand in 2025 to $23.47 million in 2021, and is currently $133 thousand as of their latest financial filing in 2025.

Over the last 5 years, Equus Total Return's book value per share changed from 0.00 in 2020 to 11.05 in 2025, a change of 1,105.4%.



Financial statements for NYSE:EQS last updated on 7/16/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners